474 related articles for article (PubMed ID: 25633905)
21. Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations.
Riches JC; O'Donovan CJ; Kingdon SJ; McClanahan F; Clear AJ; Neuberg DS; Werner L; Croce CM; Ramsay AG; Rassenti LZ; Kipps TJ; Gribben JG
Blood; 2014 Jun; 123(26):4101-10. PubMed ID: 24829201
[TBL] [Abstract][Full Text] [Related]
22. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.
Del Giudice I; Rossi D; Chiaretti S; Marinelli M; Tavolaro S; Gabrielli S; Laurenti L; Marasca R; Rasi S; Fangazio M; Guarini A; Gaidano G; Foà R
Haematologica; 2012 Mar; 97(3):437-41. PubMed ID: 22207691
[TBL] [Abstract][Full Text] [Related]
23. Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia.
Maura F; Mosca L; Fabris S; Cutrona G; Matis S; Lionetti M; Agnelli L; Barbieri M; D'Anca M; Manzoni M; Colombo M; Massucco C; Reverberi D; Gentile M; Recchia AG; Bossio S; Ilariucci F; Musolino C; Di Raimondo F; Cortelezzi A; Morabito F; Ferrarini M; Neri A
PLoS One; 2015; 10(3):e0118801. PubMed ID: 25786252
[TBL] [Abstract][Full Text] [Related]
24. Active Akt signaling triggers CLL toward Richter transformation via overactivation of Notch1.
Kohlhaas V; Blakemore SJ; Al-Maarri M; Nickel N; Pal M; Roth A; Hövelmeyer N; Schäfer SC; Knittel G; Lohneis P; Nikolic M; Wiederstein JL; Franitza M; Georgomonolis T; Reinart N; Herling M; Herling C; Hartmann EM; Rosenwald A; Klapper W; Büttner R; Moia R; Rossi D; Boldorini R; Gaidano G; Frenzel LP; Reinhardt HC; Brüning JC; Hallek M; Krüger M; Peifer M; Pallasch CP; Wunderlich FT
Blood; 2021 Feb; 137(5):646-660. PubMed ID: 33538798
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells.
Pickering BM; de Mel S; Lee M; Howell M; Habens F; Dallman CL; Neville LA; Potter KN; Mann J; Mann DA; Johnson PW; Stevenson FK; Packham G
Oncogene; 2007 Feb; 26(8):1166-77. PubMed ID: 16924235
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis.
Munzert G; Kirchner D; Stobbe H; Bergmann L; Schmid RM; Döhner H; Heimpel H
Blood; 2002 Nov; 100(10):3749-56. PubMed ID: 12411322
[TBL] [Abstract][Full Text] [Related]
27. High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications.
Lionetti M; Fabris S; Cutrona G; Agnelli L; Ciardullo C; Matis S; Ciceri G; Colombo M; Maura F; Mosca L; Gentile M; Recchia AG; Ilariucci F; Musolino C; Molica S; Di Raimondo F; Cortelezzi A; Rossi D; Gaidano G; Morabito F; Ferrarini M; Neri A
Br J Haematol; 2014 Jun; 165(5):629-39. PubMed ID: 24579978
[TBL] [Abstract][Full Text] [Related]
28. Common nonmutational
Fabbri G; Holmes AB; Viganotti M; Scuoppo C; Belver L; Herranz D; Yan XJ; Kieso Y; Rossi D; Gaidano G; Chiorazzi N; Ferrando AA; Dalla-Favera R
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2911-E2919. PubMed ID: 28314854
[TBL] [Abstract][Full Text] [Related]
29. B-chronic lymphocytic leukemia cells contain both endogenous kappa immunoglobulin mRNA and critical immunoglobulin gene activation transcription factors.
Zaknoen SL; Christian SL; Suen R; Van Ness B; Kay NE
Leukemia; 1992 Jul; 6(7):675-9. PubMed ID: 1625486
[TBL] [Abstract][Full Text] [Related]
30. Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1/Akt/NF-κB pathway.
Zou W; Ma X; Hua W; Chen B; Cai G
Oncol Rep; 2015 Dec; 34(6):3256-63. PubMed ID: 26503358
[TBL] [Abstract][Full Text] [Related]
31. Gliotoxin is a potent NOTCH2 transactivation inhibitor and efficiently induces apoptosis in chronic lymphocytic leukaemia (CLL) cells.
Hubmann R; Hilgarth M; Schnabl S; Ponath E; Reiter M; Demirtas D; Sieghart W; Valent P; Zielinski C; Jäger U; Shehata M
Br J Haematol; 2013 Mar; 160(5):618-29. PubMed ID: 23278106
[TBL] [Abstract][Full Text] [Related]
32. Frequencies of SF3B1, NOTCH1, MYD88, BIRC3 and IGHV mutations and TP53 disruptions in Chinese with chronic lymphocytic leukemia: disparities with Europeans.
Xia Y; Fan L; Wang L; Gale RP; Wang M; Tian T; Wu W; Yu L; Chen YY; Xu W; Li JY
Oncotarget; 2015 Mar; 6(7):5426-34. PubMed ID: 25605254
[TBL] [Abstract][Full Text] [Related]
33. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia.
Migliazza A; Bosch F; Komatsu H; Cayanis E; Martinotti S; Toniato E; Guccione E; Qu X; Chien M; Murty VV; Gaidano G; Inghirami G; Zhang P; Fischer S; Kalachikov SM; Russo J; Edelman I; Efstratiadis A; Dalla-Favera R
Blood; 2001 Apr; 97(7):2098-104. PubMed ID: 11264177
[TBL] [Abstract][Full Text] [Related]
34. The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells.
López-Guerra M; Xargay-Torrent S; Rosich L; Montraveta A; Roldán J; Matas-Céspedes A; Villamor N; Aymerich M; López-Otín C; Pérez-Galán P; Roué G; Campo E; Colomer D
Leukemia; 2015 Jan; 29(1):96-106. PubMed ID: 24781018
[TBL] [Abstract][Full Text] [Related]
35. p65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IkappaB kinase inhibitor BMS-345541.
López-Guerra M; Roué G; Pérez-Galán P; Alonso R; Villamor N; Montserrat E; Campo E; Colomer D
Clin Cancer Res; 2009 Apr; 15(8):2767-76. PubMed ID: 19351760
[TBL] [Abstract][Full Text] [Related]
36. IL-4-dependent Jagged1 expression/processing is associated with survival of chronic lymphocytic leukemia cells but not with Notch activation.
De Falco F; Del Papa B; Baldoni S; Sabatini R; Falzetti F; Di Ianni M; Martelli MP; Mezzasoma F; Pelullo M; Marconi P; Sportoletti P; Screpanti I; Rosati E
Cell Death Dis; 2018 Nov; 9(12):1160. PubMed ID: 30478302
[TBL] [Abstract][Full Text] [Related]
37. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
Puiggros A; Venturas M; Salido M; Blanco G; Fernandez-Rodriguez C; Collado R; Valiente A; Ruiz-Xivillé N; Carrió A; Ortuño FJ; Luño E; Calasanz MJ; Ardanaz MT; Piñán MÁ; Talavera E; González MT; Ortega M; Marugán I; Ferrer A; Gimeno E; Bellosillo B; Delgado J; Hernández JÁ; Hernández-Rivas JM; Espinet B; ;
Genes Chromosomes Cancer; 2014 Sep; 53(9):788-97. PubMed ID: 24915757
[TBL] [Abstract][Full Text] [Related]
38. Activation-induced cytidine deaminase splicing patterns in chronic lymphocytic leukemia.
Marantidou F; Dagklis A; Stalika E; Korkolopoulou P; Saetta A; Anagnostopoulos A; Laoutaris N; Stamatopoulos K; Belessi C; Scouras Z; Patsouris E
Blood Cells Mol Dis; 2010 Apr; 44(4):262-7. PubMed ID: 20117026
[TBL] [Abstract][Full Text] [Related]
39. Dichotomy in NF-kappaB signaling and chemoresistance in immunoglobulin variable heavy-chain-mutated versus unmutated CLL cells upon CD40/TLR9 triggering.
Tromp JM; Tonino SH; Elias JA; Jaspers A; Luijks DM; Kater AP; van Lier RA; van Oers MH; Eldering E
Oncogene; 2010 Sep; 29(36):5071-82. PubMed ID: 20581863
[TBL] [Abstract][Full Text] [Related]
40. Survival of leukemic B cells promoted by engagement of the antigen receptor.
Bernal A; Pastore RD; Asgary Z; Keller SA; Cesarman E; Liou HC; Schattner EJ
Blood; 2001 Nov; 98(10):3050-7. PubMed ID: 11698290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
